Zobrazeno 1 - 10
of 1 116
pro vyhledávání: '"de Mey C"'
Autor:
Duvillier L; Department of Cardiology, Heart Center, Ghent University Hospital, Ghent, Belgium., Demolder A; Department of Cardiology, Heart Center, Ghent University Hospital, Ghent, Belgium., Van Renterghem S; Department of Cardiology, Heart Center, Ghent University Hospital, Ghent, Belgium., De Mey C; Department of Cardiology, Heart Center, Ghent University Hospital, Ghent, Belgium., West F; Department of Cardiology, Heart Center, Ghent University Hospital, Ghent, Belgium., De Pooter J; Department of Cardiology, Heart Center, Ghent University Hospital, Ghent, Belgium.
Publikováno v:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2024 Nov; Vol. 35 (11), pp. 2134-2143. Date of Electronic Publication: 2024 Sep 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 53:247-255
BACKGROUND Flupirtine is a nonopioid, central analgesic without antipyretic or antiphlogistic properties. Flupirtine-MR is an oral modified-release formulation with a 100 mg fast-input and a 300 mg portion with slow protracted release. METHODS Single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff6c578a7f90b8d400009310a337e75
https://doi.org/10.5414/cp202236
https://doi.org/10.5414/cp202236
Autor:
Volk A; Virus and Prion Validation, Octapharma Biopharmaceuticals GmbH, Frankfurt, Germany. andreas.volk@octapharma.com., Covini-Souris C; R&D Plasma, Octapharma Pharmazeutika Produktionsgesellschaft m.b.H., Vienna, Austria., Kuehnel D; Virus and Prion Validation, Octapharma Biopharmaceuticals GmbH, Frankfurt, Germany., De Mey C; ACPS-Network GmbH, Wiesbaden, Germany., Römisch J; R&D Plasma, Octapharma Pharmazeutika Produktionsgesellschaft m.b.H., Vienna, Austria., Schmidt T; Virus and Prion Validation, Octapharma Biopharmaceuticals GmbH, Frankfurt, Germany.
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2022 Jan; Vol. 36 (1), pp. 41-53. Date of Electronic Publication: 2021 Nov 29.
Publikováno v:
Arzneimittelforschung. 49:351-358
This multicenter, placebo-controlled, double-blind, randomized parallel-group trial was conducted to investigate the efficacy and tolerability of myrtol standardized (MYS, Gelomyrtol forte, 3 x 300 mg) in the long-term treatment of patients with chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9acd1c9418085dfb50172ee2744c39d1
https://doi.org/10.1055/s-0031-1300426
https://doi.org/10.1055/s-0031-1300426
Autor:
Salikin NH; School of Industrial Technology, Universiti Sains Malaysia, 11800, Minden Pulau Pinang, Malaysia., Keong LC; School of Industrial Technology, Universiti Sains Malaysia, 11800, Minden Pulau Pinang, Malaysia., Azemin WA; School of Biological Sciences, Universiti Sains Malaysia, 11800, Minden Pulau Pinang, Malaysia., Philip N; School of Biological Sciences, Universiti Sains Malaysia, 11800, Minden Pulau Pinang, Malaysia., Yusuf N; Department of Chemistry, Faculty of Mathematics and Natural Sciences, Syiah Kuala University, Aceh, Indonesia., Daud SA; School of Biological Sciences, Universiti Sains Malaysia, 11800, Minden Pulau Pinang, Malaysia., Rashid SA; School of Biological Sciences, Universiti Sains Malaysia, 11800, Minden Pulau Pinang, Malaysia. syarifahabrashid@usm.my.
Publikováno v:
World journal of microbiology & biotechnology [World J Microbiol Biotechnol] 2024 Dec 04; Vol. 40 (12), pp. 402. Date of Electronic Publication: 2024 Dec 04.
Publikováno v:
Drug Research; 2016, Vol. 66 Issue 7, p384-392, 9p
Autor:
de Mey C
Publikováno v:
Current Medical Research and Opinion. 14:187-202
Erectile function in man depends upon a complex interaction of psychogenic, neurologic, hormonal and vascular factors, and therefore the management of erectile dysfunction (ED) reflects this complexity of control. Therapeutic options include psycholo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fbd380d50fe817dbe205768c6ecaa18
https://doi.org/10.1185/03007999809113359
https://doi.org/10.1185/03007999809113359
Publikováno v:
Drug Research; 2015, Vol. 65 Issue 12, p658-667, 10p
Publikováno v:
Clinical Pharmacology & Therapeutics, 70(2), 142-148. Nature Publishing Group
Objective. Our objective was to investigate the potential for relevant pharmacotherapeutic interaction between cytochrome P4503A4 (CYP3A4)-inhibiting agents such as erythromycin and the dopamine agonist alpha -dihydroergocryptine (DHEC). Methods. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e1379784b2e3272dcc0ce73ef96c734a
https://research.rug.nl/en/publications/658fcea6-d92b-4bcb-a3bd-1f408f7926e0
https://research.rug.nl/en/publications/658fcea6-d92b-4bcb-a3bd-1f408f7926e0
